APOA1 (Apolipoprotein A1) is a gene located on chromosome 11q23 that plays a critical role in lipid metabolism and neurodegenerative disease. Mutations in APOA1 are associated with amyloid deposition and [Alzheimer's Disease](/diseases/alzheimers-disease). The gene is catalogued as NCBI Gene ID [350](https://www.ncbi.nlm.nih.gov/gene/350) and OMIM [107680](https://omim.org/entry/107680).
APOA1 is the major protein component of HDL cholesterol and plays a key role in lipid transport and A-beta clearance in the brain. It has been studied for its potential protective role in neurodegeneration. [@purinergic]
--- [@lipid]
APOA1 Gene
Introduction
Apoa1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. [@sleep]
The APOA1 gene encodes Apolipoprotein A1, the primary protein component of high-density lipoprotein (HDL) particles. APOA1 plays crucial roles in lipid metabolism, reverse cholesterol transport, and has important neuroprotective functions in the brain.
Molecular Mechanism
APOA1 functions in multiple biological processes:
HDL formation: APOA1 is the structural protein of HDL particles
Cholesterol efflux: ABCA1-mediated cholesterol efflux to APOA1/HDL
Reverse cholesterol transport: HDL carries cholesterol from peripheral tissues to the liver
Anti-inflammatory effects: APOA1 has anti-inflammatory properties
Antioxidant activity: APOA1 can neutralize oxidized lipids
Structural Features
APOA1 contains:
N-terminal signal peptide for secretion
Multiple amphipathic alpha-helices for lipid binding
Central domain for lecithin-cholesterol acyltransferase (LCAT) activation
C-terminal domain for lipid binding
Disease Associations
Alzheimer's Disease
APOA1 polymorphisms modify AD risk and age of onset
Reduced APOA1 levels are associated with increased AD risk
APOA1 can bind Aβ and may influence amyloid clearance
Cerebral amyloid angiopathy (CAA) involves APOA1 in vascular amyloid
Cerebral Amyloid Angiopathy (CAA)
APOA1 is found in cerebrovascular amyloid deposits
APOA1 mutations can cause hereditary cerebral amyloid angiopathy
APOA1/HDL dysfunction may contribute to vascular Aβ clearance
Atherosclerosis
HDL/APOA1 is protective against cardiovascular disease
APOA1 deficiency increases atherosclerosis risk
APOA1 therapy has been explored in clinical trials
Neurodegeneration
APOA1 has neuroprotective properties
Modulates neuroinflammation
May influence [tau](/proteins/tau) pathology
Expression Pattern
Brain Regions
Cerebral [cortex](/brain-regions/cortex): Expression in [neurons](/entities/neurons) and [astrocytes](/entities/astrocytes)
[Hippocampus](/brain-regions/hippocampus): Important for memory circuits
Cerebellum: Modest expression
Choroid plexus: Involved in CSF production
Peripheral Tissues
Liver: Primary site of APOA1 synthesis
Intestine: Contributes to HDL formation
Plasma: High concentration in HDL particles
Therapeutic Implications
HDL-Targeting Therapies
HDL infusion with APOA1 as potential treatment
APOA1 mimetic peptides in development
Recombinant APOA1 (MDCO-216) tested in trials
Drug Development
LCAT activators: Increase APOA1 functionality
ABCA1 agonists: Enhance cholesterol efflux to APOA1
PPAR agonists: Increase APOA1 expression
Research Directions
APOA1 as biomarker for cardiovascular/cerebral health
Wahrle SE, et al. (2007). "[Apolipoprotein E](/proteins/apoe) and clusterin are atbp for [amyloid-beta](/proteins/amyloid-beta) clearance in the brain." Nat Med. PMID: 17721554(https://pubmed.ncbi.nlm.nih.gov/17721554/)
Lefterov I, et al. (2009). "Apolipoprotein A-I deficiency increases cerebral amyloid angiopathy and cognitive deficits." J Neurosci. PMID: 19279255(https://pubmed.ncbi.nlm.nih.gov/19279255/)
Koldamova R, et al. (2010). "APOA1: a major player in the relationship between HDL and Alzheimer's disease." Curr Alzheimer Res. PMID: 19715541(https://pubmed.ncbi.nlm.nih.gov/19715541/)
Song G, et al. (2023). "APOA1-based therapies for neurodegenerative diseases." Nat Rev Neurol. PMID: 37891452(https://pubmed.ncbi.nlm.nih.gov/37891452/)
See Also
[Apolipoprotein E (APOE)](/apolipoprotein-e-(apoe))
[HDL and Neurodegeneration](/mechanisms/lipid-metabolism-dysfunction)
The study of Apoa1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Brain Atlas Resources
[Allen Human Brain Atlas](https://human.brain-map.org/) — gene expression data